Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Assessment of potential drug interactions by characterization of human drug metabolism pathways using non‐invasive bile sampling2012 · 20 citations
2. 2Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis2014 · 97 citations
3. 3Circulating Hematopoietic Progenitor Cells are Decreased in COPD2013 · 27 citations
4. 4Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor2005 · 169 citations
5. 5Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis2008 · 119 citations